Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. HSD17B13 and Chronic Liver Disease in Blacks and Hispanics

    Research output: Contribution to journalComment/debateResearch

  4. A Novel Familial Cardiac Arrhythmia Syndrome with Widespread ST-Segment Depression

    Research output: Contribution to journalLetterResearchpeer-review

  5. Classification and Personalized Prognosis in Myeloproliferative Neoplasms

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Interlead electrical delays and scar tissue: Response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition would result in efficacy and safety similar to those with continued intravenous treatment is unknown. Methods In a randomized, noninferiority, multicenter trial, we assigned 400 adults in stable condition who had endocarditis on the left side of the heart caused by streptococcus, Enterococcus faecalis, Staphylococcus aureus, or coagulase-negative staphylococci and who were being treated with intravenous antibiotics to continue intravenous treatment (199 patients) or to switch to oral antibiotic treatment (201 patients). In all patients, antibiotic treatment was administered intravenously for at least 10 days. If feasible, patients in the orally treated group were discharged to outpatient treatment. The primary outcome was a composite of all-cause mortality, unplanned cardiac surgery, embolic events, or relapse of bacteremia with the primary pathogen, from the time of randomization until 6 months after antibiotic treatment was completed. Results After randomization, antibiotic treatment was completed after a median of 19 days (interquartile range, 14 to 25) in the intravenously treated group and 17 days (interquartile range, 14 to 25) in the orally treated group (P=0.48). The primary composite outcome occurred in 24 patients (12.1%) in the intravenously treated group and in 18 (9.0%) in the orally treated group (between-group difference, 3.1 percentage points; 95% confidence interval, -3.4 to 9.6; P=0.40), which met noninferiority criteria. Conclusions In patients with endocarditis on the left side of the heart who were in stable condition, changing to oral antibiotic treatment was noninferior to continued intravenous antibiotic treatment. (Funded by the Danish Heart Foundation and others; POET ClinicalTrials.gov number, NCT01375257 .).

Original languageEnglish
JournalThe New England journal of medicine
Volume380
Issue number5
Pages (from-to)415-424
ISSN0028-4793
DOIs
Publication statusPublished - 2019

ID: 55417028